Literature DB >> 18785161

Phenotypic analysis of human embryonic stem cells.

Mark Ungrin1, Michael O'Connor, Connie Eaves, Peter W Zandstra.   

Abstract

Human embryonic stem cells (hESCs) are an important tool for the study of developmental biology and may one day serve as a source of cells for regenerative medicine. As no definitive assay for hESC pluripotency is available, surrogate assays that measure markers or properties that have been correlated with hESC developmental potential are used to measure the effects of test conditions on their propagation and differentiation. This unit presents a range of protocols, including visual inspection, flow cytometry, immunofluorescence, quantitative real-time reverse-transcriptase PCR, and a colony-forming assay, as tools to measure the undifferentiated hESC state. The authors discuss the advantages and limitations of the various protocols, and present expected results and discuss potential problems. The development of quantitative assays of hESC developmental potential are critical for our understanding of hESC biology. Copyright 2007 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18785161     DOI: 10.1002/9780470151808.sc01b03s2

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  10 in total

1.  Distinct Metabolic States Can Support Self-Renewal and Lipogenesis in Human Pluripotent Stem Cells under Different Culture Conditions.

Authors:  Hui Zhang; Mehmet G Badur; Ajit S Divakaruni; Seth J Parker; Christian Jäger; Karsten Hiller; Anne N Murphy; Christian M Metallo
Journal:  Cell Rep       Date:  2016-07-28       Impact factor: 9.423

2.  High-throughput screening assay for embryoid body differentiation of human embryonic stem cells.

Authors:  Joel T Outten; Paul Gadue; Deborah L French; Scott L Diamond
Journal:  Curr Protoc Stem Cell Biol       Date:  2012-03

3.  A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells.

Authors:  Julien Maruotti; Karl Wahlin; David Gorrell; Imran Bhutto; Gerard Lutty; Donald J Zack
Journal:  Stem Cells Transl Med       Date:  2013-04-12       Impact factor: 6.940

Review 4.  Stems cells, big data and compendium-based analyses for identifying cell types, signalling pathways and gene regulatory networks.

Authors:  Md Humayun Kabir; Michael D O'Connor
Journal:  Biophys Rev       Date:  2019-01-25

5.  Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells.

Authors:  Celine L Bauwens; Derek Toms; Mark Ungrin
Journal:  J Vis Exp       Date:  2016-09-25       Impact factor: 1.355

6.  Application of the RBBP9 Serine Hydrolase Inhibitor, ML114, Decouples Human Pluripotent Stem Cell Proliferation and Differentiation.

Authors:  Seakcheng Lim; Rachel A Shparberg; Jens R Coorssen; Michael D O'Connor
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

7.  Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates.

Authors:  Mark D Ungrin; Chirag Joshi; Andra Nica; Céline Bauwens; Peter W Zandstra
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

Review 8.  The 3R principle: advancing clinical application of human pluripotent stem cells.

Authors:  Michael D O'Connor
Journal:  Stem Cell Res Ther       Date:  2013-03-08       Impact factor: 6.832

9.  Light-focusing human micro-lenses generated from pluripotent stem cells model lens development and drug-induced cataract in vitro.

Authors:  Patricia Murphy; Md Humayun Kabir; Tarini Srivastava; Michele E Mason; Chitra U Dewi; Seakcheng Lim; Andrian Yang; Djordje Djordjevic; Murray C Killingsworth; Joshua W K Ho; David G Harman; Michael D O'Connor
Journal:  Development       Date:  2018-01-09       Impact factor: 6.868

Review 10.  Human Cell Atlas and cell-type authentication for regenerative medicine.

Authors:  Yulia Panina; Peter Karagiannis; Andreas Kurtz; Glyn N Stacey; Wataru Fujibuchi
Journal:  Exp Mol Med       Date:  2020-09-15       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.